Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged 2023-04-17 07:45
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark 2023-04-17 07:00
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical 2023-04-17 06:38
Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its Global Phase 3 MRCT 2023-04-14 19:00
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering 2023-04-14 08:00
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults 2023-04-14 01:15
The Dates of the XXVII Edition of the International Fair Play Menarini Awards 2023-04-13 18:50
Caring Pharmacy partners with Appier to deliver a personalized multi-channel experience for Malaysians 2023-04-13 14:00
EW GROUP SHINES AT 12TH A4M SYMPOSIUM 2023 & "ALL-ON BIOREGEN OPTIMIZATION" WORKSHOP 2023-04-13 12:20
Viva Biotech Attended SAPA-China 2023-04-13 11:33
Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023 2023-04-13 08:00
Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis 2023-04-13 06:00
Standigm announces Younsung Choo as chief executive officer 2023-04-13 00:07
GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications 2023-04-12 11:06
Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia 2023-04-12 06:00
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil 2023-04-11 20:19
OnCusp Therapeutics Showcases Potent Anti-Tumor Activity of its CDH6 ADC at AACR Annual Meeting 2023 2023-04-11 20:00
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors 2023-04-11 19:00
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate 2023-04-11 05:00
Asieris' subsidiary makes significant progress in its commercialization strategy by obtaining the "Drug Distribution License" 2023-04-10 20:18
1 75 76 77 78 79 377